Last updated on November 2018

Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection


Brief description of study

The objectives of this study are:

  • to evaluate the safety, tolerability, and systemic pharmacokinetics (PK) of different doses of inhaled ALX-0171 in Japanese infants and young children hospitalized for respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI).
  • to evaluate the antiviral effect, clinical activity, immunogenicity, and pharmacodynamics (PD) of different doses of inhaled ALX-0171 in Japanese infants and young children hospitalized for RSV LRTI.

Clinical Study Identifier: NCT03418571

Contact Investigators or Research Sites near you

Start Over

Ablynx NV Belgium

Investigator Site
Shimotsuke-shi, Japan
6.27miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.